Safilo Group S.p.A. (SAFLF)
USD 0.98
(0.0%)
USD 0.98
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 7.66 Million EUR | -84.19% |
| 2022 | 48.45 Million EUR | 85.84% |
| 2021 | 26.07 Million EUR | 131.26% |
| 2020 | -83.42 Million EUR | 69.3% |
| 2019 | -271.74 Million EUR | -3678.85% |
| 2018 | 7.59 Million EUR | 103.65% |
| 2017 | -208.17 Million EUR | -79.05% |
| 2016 | -116.26 Million EUR | -14074.4% |
| 2015 | 832 Thousand EUR | -98.89% |
| 2014 | 75.26 Million EUR | 0.73% |
| 2013 | 74.72 Million EUR | 1.15% |
| 2012 | 73.87 Million EUR | -14.28% |
| 2011 | 86.18 Million EUR | 27.11% |
| 2010 | 67.8 Million EUR | 125.05% |
| 2009 | -270.68 Million EUR | -413.52% |
| 2008 | 86.33 Million EUR | -36.45% |
| 2007 | 135.85 Million EUR | 8.19% |
| 2006 | 125.57 Million EUR | 6.54% |
| 2005 | 117.86 Million EUR | 5.89% |
| 2004 | 111.31 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 39.6 Million USD | -17.06% |
| 2023 FY | 7.66 Million EUR | -84.19% |
| 2023 Q4 | -11.18 Million USD | -366.21% |
| 2023 Q3 | 4.2 Million EUR | -86.72% |
| 2023 Q2 | 31.64 Million USD | 80.12% |
| 2023 Q1 | 17.56 Million EUR | 39.58% |
| 2022 Q2 | 19.27 Million USD | 0.0% |
| 2022 Q4 | 12.58 Million USD | 152.3% |
| 2022 FY | 48.45 Million EUR | 85.84% |
| 2022 Q1 | 19.27 Million EUR | 359.35% |
| 2022 Q3 | 4.98 Million EUR | -74.12% |
| 2021 Q3 | 4.19 Million EUR | -65.9% |
| 2021 Q2 | 12.3 Million USD | 0.0% |
| 2021 FY | 26.07 Million EUR | 131.26% |
| 2021 Q1 | 12.3 Million EUR | 470.1% |
| 2021 Q4 | 4.19 Million USD | 0.0% |
| 2020 Q3 | 2.15 Million EUR | 106.59% |
| 2020 FY | -83.42 Million EUR | 69.3% |
| 2020 Q1 | -32.74 Million EUR | -582.61% |
| 2020 Q2 | -32.74 Million USD | 0.0% |
| 2020 Q4 | 2.15 Million USD | 0.0% |
| 2019 Q3 | -4.79 Million EUR | -133.88% |
| 2019 Q1 | 6.64 Million EUR | 191.53% |
| 2019 FY | -271.74 Million EUR | -3678.85% |
| 2019 Q2 | 14.15 Million EUR | 112.91% |
| 2019 Q4 | -4.79 Million USD | 0.0% |
| 2018 Q3 | -7.26 Million EUR | -37.76% |
| 2018 Q4 | -7.26 Million EUR | 0.0% |
| 2018 FY | 7.59 Million EUR | 103.65% |
| 2018 Q1 | -5.27 Million EUR | 63.51% |
| 2018 Q2 | -5.27 Million EUR | 0.0% |
| 2017 Q1 | -7.22 Million EUR | -291.38% |
| 2017 Q4 | -14.45 Million EUR | 0.0% |
| 2017 Q3 | -14.45 Million EUR | -100.1% |
| 2017 FY | -208.17 Million EUR | -79.05% |
| 2017 Q2 | -7.22 Million EUR | 0.0% |
| 2016 FY | -116.26 Million EUR | -14074.4% |
| 2016 Q2 | 18.8 Million EUR | 0.0% |
| 2016 Q4 | -1.84 Million EUR | 0.0% |
| 2016 Q3 | -1.84 Million EUR | -109.82% |
| 2016 Q1 | 18.8 Million EUR | 142.33% |
| 2015 FY | 832 Thousand EUR | -98.89% |
| 2015 Q4 | -44.41 Million EUR | -1079.88% |
| 2015 Q3 | 4.53 Million EUR | -75.61% |
| 2015 Q2 | 18.58 Million EUR | -16.01% |
| 2015 Q1 | 22.13 Million EUR | 22.44% |
| 2014 Q1 | 26.81 Million EUR | 30.05% |
| 2014 Q4 | 18.07 Million EUR | 217.87% |
| 2014 Q3 | 5.68 Million EUR | -76.97% |
| 2014 Q2 | 24.68 Million EUR | -7.94% |
| 2014 FY | 75.26 Million EUR | 0.73% |
| 2013 FY | 74.72 Million EUR | 1.15% |
| 2013 Q2 | 21.52 Million EUR | -16.31% |
| 2013 Q4 | 20.62 Million EUR | 200.9% |
| 2013 Q1 | 25.72 Million EUR | 51.13% |
| 2013 Q3 | 6.85 Million EUR | -68.17% |
| 2012 Q1 | 23.09 Million EUR | 42.99% |
| 2012 Q3 | 5.66 Million EUR | -79.82% |
| 2012 Q4 | 17.02 Million EUR | 200.25% |
| 2012 FY | 73.87 Million EUR | -14.28% |
| 2012 Q2 | 28.09 Million EUR | 21.63% |
| 2011 Q2 | 30.48 Million EUR | -2.88% |
| 2011 Q4 | 16.15 Million EUR | 97.61% |
| 2011 FY | 86.18 Million EUR | 27.11% |
| 2011 Q3 | 8.17 Million EUR | -73.19% |
| 2011 Q1 | 31.38 Million EUR | 103.53% |
| 2010 Q2 | 20.55 Million EUR | -14.75% |
| 2010 FY | 67.8 Million EUR | 125.05% |
| 2010 Q3 | 7.72 Million EUR | -62.42% |
| 2010 Q1 | 24.1 Million EUR | 117.7% |
| 2010 Q4 | 15.41 Million EUR | 99.62% |
| 2009 Q1 | 19.11 Million EUR | 0.0% |
| 2009 FY | -270.68 Million EUR | -413.52% |
| 2009 Q4 | -136.22 Million EUR | -282.61% |
| 2009 Q3 | -35.6 Million EUR | 69.82% |
| 2009 Q2 | -117.96 Million EUR | -717.24% |
| 2008 FY | 86.33 Million EUR | -36.45% |
| 2007 FY | 135.85 Million EUR | 8.19% |
| 2006 FY | 125.57 Million EUR | 6.54% |
| 2005 FY | 117.86 Million EUR | 5.89% |
| 2004 FY | 111.31 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | -558.037% |
| Ansell Limited | 129.3 Million USD | 94.075% |
| Ansell Limited | 129.3 Million USD | 94.075% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 31.13 Million USD | 75.397% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | 580.102% |
| Psykey, Inc. | -797.5 Thousand USD | 1060.622% |
| ConvaTec Group Plc | 262.7 Million USD | 97.084% |
| ConvaTec Group Plc | 262.7 Million USD | 97.084% |
| Encision Inc. | -640.78 Thousand USD | 1295.569% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 5502.299% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 7068.98% |
| Innovative MedTech Inc. | -4.27 Million USD | 279.243% |
| LifePoint, Inc. | -7.49 Million USD | 202.212% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 218.225% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | -2221.515% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | 6334.03% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | 1739.495% |
| SmileDirectClub, Inc. | -241.15 Million USD | 103.177% |
| Sector 10, Inc. | -39.84 Thousand USD | 19327.487% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | 97.603% |
| SheerVision, Inc. | 155.72 Thousand USD | -4819.538% |
| United Health Products, Inc. | -2.42 Million USD | 415.717% |
| Vasamed, Inc. | 4.74 Million USD | -61.546% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | 433.938% |
| Yubo International Biotech Limited | -1.2 Million USD | 735.65% |